Ping Zhang - Jan 5, 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Ping Zhang
Stock symbol
GYRE
Transactions as of
Jan 5, 2025
Transactions value $
$0
Form type
4
Date filed
1/7/2025, 04:05 PM
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +52K $0.00 52K Jan 5, 2025 Common Stock 52K $10.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 52,000 shares of the Issuer's common stock, which will vest in 36 equal monthly installments through January 5, 2028, subject to the Reporting Person's continued service to the Issuer through each vesting date.